Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Matthew S. Kelly, MD, MPH (he/him/his)

Professor of Pediatrics
University of Arkansas for Medical Sciences
Little Rock, AR, United States

Matthew Kelly, MD, MPH is the Horace C. Cabe Distinguished Chair in Infectious Diseases, Professor of Pediatrics in the Division of Infectious Diseases, and Section Chief of Infectious Diseases at Arkansas Children’s Hospital and the University of Arkansas for Medical Sciences. He received his medical degree from Harvard Medical School and his MPH degree from the Harvard School of Public Health before completing his pediatrics training in the Boston Combined Residency Program in Pediatrics. He was a David N. Pincus Pediatric Global Health Fellow through the Children's Hospital of Philadelphia, during which he worked as a pediatric hospitalist in Gaborone, Botswana and started an international research program focused on childhood pneumonia. He completed pediatric infectious diseases training at Duke University where his fellowship research focused on investigating the impact of the respiratory microbiome on the risk and severity of childhood respiratory infections. During his 8 years on the Duke faculty, Dr. Kelly served as Co-Director of the Duke Microbiome Center, Program Director of the Pediatric Infectious Diseases Fellowship, and Director of Research in the Division of Pediatric Infectious Diseases. He also played key roles in physician-scientist training as Associate Director of the Duke Pediatric Research Scholars Program and Associate Program Director for Physician-Scientist Development in the Duke University Office of Pediatric Education. He received the Pediatric Infectious Diseases Society Young Investigator Award in 2022 and currently serves as Co-Chair of the Research Subcommittee for this society. He is also a co-founder of the Child Pneumonia Working Group in the International Union Against Tuberculosis and Lung Disease. His long-term career goal is to develop novel microbiome-based strategies for the prevention and treatment of childhood infections, particularly those for which the highest burden is among children in low- and middle-income countries.

Disclosure(s): Merck and Company, Inc.: Advisor/Consultant, Grant/Research Support

Presentation(s):